• Je něco špatně v tomto záznamu ?

Neutrophils in Cancer immunotherapy: friends or foes

X. Huang, E. Nepovimova, V. Adam, L. Sivak, Z. Heger, M. Valko, Q. Wu, K. Kuca

. 2024 ; 23 (1) : 107. [pub] 20240518

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc24013900

Neutrophils play a Janus-faced role in the complex landscape of cancer pathogenesis and immunotherapy. As immune defense cells, neutrophils release toxic substances, including reactive oxygen species and matrix metalloproteinase 9, within the tumor microenvironment. They also modulate the expression of tumor necrosis factor-related apoptosis-inducing ligand and Fas ligand, augmenting their capacity to induce tumor cell apoptosis. Their involvement in antitumor immune regulation synergistically activates a network of immune cells, bolstering anticancer effects. Paradoxically, neutrophils can succumb to the influence of tumors, triggering signaling cascades such as JAK/STAT, which deactivate the immune system network, thereby promoting immune evasion by malignant cells. Additionally, neutrophil granular constituents, such as neutrophil elastase and vascular endothelial growth factor, intricately fuel tumor cell proliferation, metastasis, and angiogenesis. Understanding the mechanisms that guide neutrophils to collaborate with other immune cells for comprehensive tumor eradication is crucial to enhancing the efficacy of cancer therapeutics. In this review, we illuminate the underlying mechanisms governing neutrophil-mediated support or inhibition of tumor progression, with a particular focus on elucidating the internal and external factors that influence neutrophil polarization. We provide an overview of recent advances in clinical research regarding the involvement of neutrophils in cancer therapy. Moreover, the future prospects and limitations of neutrophil research are discussed, aiming to provide fresh insights for the development of innovative cancer treatment strategies targeting neutrophils.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24013900
003      
CZ-PrNML
005      
20240905133925.0
007      
ta
008      
240725s2024 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s12943-024-02004-z $2 doi
035    __
$a (PubMed)38760815
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Huang, Xueqin $u College of Life Science, Yangtze University, Jingzhou, 434025, China
245    10
$a Neutrophils in Cancer immunotherapy: friends or foes / $c X. Huang, E. Nepovimova, V. Adam, L. Sivak, Z. Heger, M. Valko, Q. Wu, K. Kuca
520    9_
$a Neutrophils play a Janus-faced role in the complex landscape of cancer pathogenesis and immunotherapy. As immune defense cells, neutrophils release toxic substances, including reactive oxygen species and matrix metalloproteinase 9, within the tumor microenvironment. They also modulate the expression of tumor necrosis factor-related apoptosis-inducing ligand and Fas ligand, augmenting their capacity to induce tumor cell apoptosis. Their involvement in antitumor immune regulation synergistically activates a network of immune cells, bolstering anticancer effects. Paradoxically, neutrophils can succumb to the influence of tumors, triggering signaling cascades such as JAK/STAT, which deactivate the immune system network, thereby promoting immune evasion by malignant cells. Additionally, neutrophil granular constituents, such as neutrophil elastase and vascular endothelial growth factor, intricately fuel tumor cell proliferation, metastasis, and angiogenesis. Understanding the mechanisms that guide neutrophils to collaborate with other immune cells for comprehensive tumor eradication is crucial to enhancing the efficacy of cancer therapeutics. In this review, we illuminate the underlying mechanisms governing neutrophil-mediated support or inhibition of tumor progression, with a particular focus on elucidating the internal and external factors that influence neutrophil polarization. We provide an overview of recent advances in clinical research regarding the involvement of neutrophils in cancer therapy. Moreover, the future prospects and limitations of neutrophil research are discussed, aiming to provide fresh insights for the development of innovative cancer treatment strategies targeting neutrophils.
650    _2
$a lidé $7 D006801
650    12
$a neutrofily $x imunologie $x metabolismus $7 D009504
650    12
$a nádory $x imunologie $x terapie $x metabolismus $x patologie $7 D009369
650    12
$a imunoterapie $x metody $7 D007167
650    12
$a nádorové mikroprostředí $x imunologie $7 D059016
650    _2
$a zvířata $7 D000818
650    _2
$a signální transdukce $7 D015398
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Nepovimova, Eugenie $u Department of Chemistry, Faculty of Science, University of Hradec Králové, 500 03, Hradec Králové, Czech Republic
700    1_
$a Adam, Vojtech $u Department of Chemistry and Biochemistry, Mendel University in Brno, 613 00, Brno, Czech Republic
700    1_
$a Sivak, Ladislav $u Department of Chemistry and Biochemistry, Mendel University in Brno, 613 00, Brno, Czech Republic
700    1_
$a Heger, Zbynek $u Department of Chemistry and Biochemistry, Mendel University in Brno, 613 00, Brno, Czech Republic
700    1_
$a Valko, Marian $u Faculty of Chemical and Food Technology, Slovak University of Technology, 812 37, Bratislava, Slovakia
700    1_
$a Wu, Qinghua $u College of Life Science, Yangtze University, Jingzhou, 434025, China. wqh212@hotmail.com $u Department of Chemistry, Faculty of Science, University of Hradec Králové, 500 03, Hradec Králové, Czech Republic. wqh212@hotmail.com
700    1_
$a Kuca, Kamil $u Department of Chemistry, Faculty of Science, University of Hradec Králové, 500 03, Hradec Králové, Czech Republic. kamil.kuca@uhk.cz $u Biomedical Research Center, University Hospital Hradec Kralove, 500 05, Hradec Kralove, Czech Republic. kamil.kuca@uhk.cz $u Andalusian Research Institute in Data Science and Computational Intelligence (DaSCI), University of Granada, Granada, Spain. kamil.kuca@uhk.cz
773    0_
$w MED00008245 $t Molecular cancer $x 1476-4598 $g Roč. 23, č. 1 (2024), s. 107
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38760815 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240725 $b ABA008
991    __
$a 20240905133919 $b ABA008
999    __
$a ok $b bmc $g 2143608 $s 1225766
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 23 $c 1 $d 107 $e 20240518 $i 1476-4598 $m Molecular cancer $n Mol Cancer $x MED00008245
LZP    __
$a Pubmed-20240725

Najít záznam

Citační ukazatele

Možnosti archivace